Clinical Inbox & Messaging AI

Art is Epic's generative AI feature inside the MyChart In Basket, drafting replies to patient medical advice messages. The name matters and is frequently miswritten: Art stands for AUGMENTED Response Technology, not Automated Response Technology. Epic's own customer documentation and every peer reviewed study of it use Augmented, and the distinction is the product's central design claim rather than a naming detail. Art never sends anything. It presents a draft; the clinician reviews it, revises it, or discards it and writes from scratch, and authorship of what reaches the patient stays with the clinician. The draft is generated by a large language model, OpenAI's GPT 4 family delivered through Epic's partnership with Microsoft, reading the patient's latest message together with relevant chart context such as current prescriptions and recent results, plus prompts configured by the individual health system. Scale separates this record from everything else in the category. Epic reported the feature in use at roughly 150 health systems and medical groups generating about 1 million drafts per month, and named deployments include Mayo Clinic, which began implementing in early 2023 and extended access across its nursing workforce, and NYU Langone. It is also the only product in this category with independent peer reviewed evidence, none of it commissioned by Epic. That literature is unusually candid about the failure modes, including clinicians reporting that drafts sometimes contained incorrect or inappropriate content and that they too often suggested an appointment. This record is scoped to Art specifically and is not an assessment of Epic Systems or of any other Epic AI feature.

Elaborate sells inbox infrastructure to health systems and physician groups, positioned as curing the in basket, though results delivery is where the company began. It was founded in 2021 in New York by Nicole Bocskocsky, previously at Oscar and Parsley Health, and raised a 10 million dollar seed round in January 2023 led by Tusk Venture Partners. The platform covers four surfaces: classification tagging and summaries of inbound patient messages for triage, protocol based result summaries sent to the patient at direct release, one click refills with summarised charts, and an analytics module that measures inbox performance over time. The analytics product has no equivalent elsewhere in this category, where vendors generally sell the automation without selling the measurement of it. Two things separate this record from its peers. The company states its mechanism plainly rather than claiming agentic autonomy, describing rules based protocols across more than thirty ambulatory specialties powered by patient clinical data. And its named customers are substantially larger than anything else in the category, including Cedars-Sinai, Community Health Network and Austin Regional Clinic, each carrying a published outcome figure. Elaborate is distributed through both the Epic Showroom and the athenahealth Marketplace, and runs a public trust centre. The company's origin is regulatory rather than technological. The 21st Century Cures Act requires immediate electronic release of test results to patients, and Elaborate was built for the consequence: patients receiving out of range values with no context, and clinicians absorbing the messages that follow.

Droxi Digital Health sells an AI agent that works the clinical inbox for primary care, running natively inside the electronic health record rather than as a separate application. The company is headquartered in Tel Aviv, was founded by Gadi Shenhar and Raveh Ben Simon, and names Drive Capital, Verissimo and AirAngels as backers. The platform ships two products. Droxi Unbox handles the inbox itself across three item types. It auto closes normal laboratory results, including results slightly outside reference ranges where it judges them clinically insignificant, and sends the patient a configurable message. It consolidates refill requests arriving by fax, portal message or e prescription onto a single screen with medication history, last refill date, recent labs and diagnoses attached, flags duplicates, and allows approval or denial of multiple medications at once. And it summarises consult notes and clinical documents, linking every summary point back to the source text in the original. Droxi Unlock is a separate product that runs a practice's Advanced Primary Care Management programme, identifying eligible Medicare patients and handling enrolment and documentation. Droxi publishes three operating figures for Unbox: 38 percent of routine work handled automatically, a 51.9 percent reduction in after hours clinical inbox work, and 5.1 or more hours returned per provider per week. The first of those is unusual and worth noting, because it states the scope of the product's autonomy rather than only its benefit. Named customer organisations include Blue Ridge Health, Valley Health, Salience Health, Primary Care Partners of South Bend, Aspire Rural Health System, Northern Counties Health Care, Stedman-Wade Health Services, Rainbow Pediatric and Interior Health in British Columbia.

Affineon Health sells an AI agent that works the clinical inbox inside the electronic health record, concentrated on two workflows: lab result disposition (Labs Core) and prescription renewals (Rx Renewals). The company was co-founded with AI Fund, Andrew Ng's venture studio, is led by co-founder and CEO David Norris, and raised a 5 million dollar round announced in February 2025. The product is unusually explicit about what it does without a clinician present. Labs Core automatically handles normal, insignificantly abnormal and CC'd results around the clock, and Affineon's own product page describes this as automating the inbox items a provider does not want to see. Results that do require clinical review are summarised and trended rather than auto handled, and the protocols deciding which is which are configurable by each practice, so the organisation rather than the vendor sets the threshold. Rx Renewals tells staff whether a request meets the prescriber's protocol or needs physician review. Affineon also runs Affineon Embed, a white label programme placing its inbox agent inside other companies' products. Commure, indexed separately here, has joined that programme, so inbox capability sold under another brand may be Affineon underneath. Integration is named for athenahealth only, where the product is listed and rated on the marketplace. Pricing is published in full as a per provider per month ladder.

MarianaAI describes itself as a research lab building healthcare AI models, delivered through CARE, which stands for Comprehensive Automation and Revenue Enhancement. Ambient documentation is one module among more than twenty, alongside autonomous medical coding, pre visit charting, order management, CDI compliance, inbox triage with auto drafted patient responses, insurance coverage checks and a MarianaGPT assistant, integrated with a claimed 50 or more EHRs and reachable in the record, in browsers and on mobile. Buyers should read the commercial framing carefully, because the vendor states it plainly: CARE is marketed on simultaneously optimising RAF scores and ICD-10 and CPT capture to lift value based and fee for service revenue by 15 to 20 percent, on capturing up to 100 percent of codes, and on doing the coding with, in its own words, absolutely no human in the loop. That combination of revenue optimisation, risk adjustment coding and advertised full autonomy is the most exposed configuration assessed in this category, and it is why several axes here grade low despite genuine technical breadth.